IQVIA HOLDINGS INC. (IQV) Stock Price, Financials & Summary

Price chart

Oct 5Oct 8Oct 13Oct 16Oct 21Oct 26Oct 29Nov 3

Key dataNov 3, 2026

Open$255.26

From 52W high−6.00%

Volume1.23M

Market cap$43.27B

P/E (TTM)31.6x

P/S (TTM)2.5x

Div yield—

Key dataNov 3, 2026

Open

$255.26

From 52W high

−6.00%

Volume

1.23M

Market cap

$43.27B

ValuationView details →

P/E (Fwd)

19.0x

EV/EBITDA

15.9x

P/E (TTM)

31.6x

RSI (14)

45.6

MomentumView details →

1D Return

+1.61%

YTD Return

+16.41%

SummaryUpdated Sep 1, 2026

IQVIA Holdings Inc. (NASDAQ:IQV) is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. Founded in 1982 and originally known as Quintiles IMS Holdings, the company changed its name to IQVIA in November 2017. Headquartered in Durham, North Carolina, IQVIA was formed through the merger of Quintiles (a clinical research organization) and IMS Health (a healthcare data and analytics company). Today, the company operates across the Americas, Europe, Africa, and the Asia-Pacific region, serving pharmaceutical, biotechnology, device and diagnostic, and consumer health companies worldwide.

Ask drillr about IQVIA HOLDINGS INC. →

ValuationView details →

P/E (Fwd)

19.0x

P/E (TTM)

31.6x

EV/EBITDA

15.9x

EV/Sales

3.3x

P/S (TTM)

2.5x

P/B (TTM)

6.5x

ProfitabilityView details →

Gross Margin

26.46%

Net Margin

8.05%

EBITDA Margin

20.78%

ROE (TTM)

20.93%

ROA (TTM)

4.57%

Asset Turnover

0.57x

GrowthView details →

Revenue YoY

+8.85%

EPS YoY

+13.20%

FCF YoY

−21.25%

Revenue CAGR 3Y

+4.21%

EPS CAGR 3Y

+10.77%

EBITDA YoY

+4.72%

MomentumView details →

1D Return

+1.61%

YTD Return

+16.41%

1Y Return

+24.38%

RSI (14)

45.6

vs 50D SMA

−1.39%

vs 200D SMA

+25.11%

Capital & dividendView details →

Debt/Equity

2.45x

Current Ratio

0.83x

Quick Ratio

0.83x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

$3.34

EPS Surprise

2.45%

Beats (12Q)

8/12

Next Q EPS Est

$3.59

Avg Surprise (4Q)

2.44%

Rev Surprise

1.44%

Financials snapshotView financials →

Revenue (TTM)

17.31B

Net Income (TTM)

1.39B

Op. CF (TTM)

2.74B

Next earningsFeb 4, 2027 →

Latest newsMore news →

IQVIA HOLDINGS INC. reported third-quarter 2026 revenue of $4.428 billion, up 8% year over year, and net income of $350 million; it also provided full-year 2026 guidance.7d ago

IQVIA HOLDINGS INC. reported quarterly earnings of $3.34 per share, above the Zacks Investment Research, Inc. Consensus Estimate of $3.24 and compared with $3 per share a year earlier.8d ago

Similar companies

Waters CorporationWAT Agilent Technologies, Inc.A Illumina, Inc.ILMN IDEXX Laboratories, Inc.IDXX 昭衍新药603127.SH Mettler-Toledo International Inc.MTD Find similar companies →

Latest newsMore news →

IQVIA HOLDINGS INC. reported third-quarter 2026 revenue of $4.428 billion, up 8% year over year, and net income of $350 million; it also provided full-year 2026 guidance.7d ago IQVIA HOLDINGS INC. reported quarterly earnings of $3.34 per share, above the Zacks Investment Research, Inc. Consensus Estimate of $3.24 and compared with $3 per share a year earlier.8d ago IQVIA HOLDINGS INC. and VEEVA SYSTEMS INC announced an extension of their partnership, with IQVIA HOLDINGS INC. selecting Veeva CTMS and eTMF applications.22d ago